Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
India has extended the its support to the Venezuela after the series of the powerful…
The Reserve Bank of India (RBI) has introduced the scale-based regulation framework for the Non-Banking…
The Bears are among the most fascinating mammals on the Planet Earth. From the icy…
The Reserve Bank of India (RBI) has finalized the compensation framework for the victims of…
India has once again earned global recognition in environmental conservation as two remarkable Indian women…
Can you imagine a place where the city and the country are exactly the same.…